XFOR logo

X4 Pharmaceuticals (XFOR) Company Overview

Profile

Full Name:

X4 Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 16, 2017

Indexes:

Not included

Description:

X4 Pharmaceuticals focuses on developing innovative therapies for rare diseases, particularly those affecting the immune system. The company aims to improve patients' lives by creating targeted treatments that address unmet medical needs, leveraging advanced science and research to bring new options to the market.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 14, 2019

Analyst ratings

Recent major analysts updates

Feb 7, 25 HC Wainwright & Co.
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Nov 14, 24 Stifel
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Jun 28, 24 HC Wainwright & Co.
Buy
May 31, 24 Cantor Fitzgerald
Overweight
Apr 30, 24 HC Wainwright & Co.
Buy
Mar 22, 24 HC Wainwright & Co.
Buy
Dec 12, 23 B. Riley Securities
Neutral
Aug 11, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for X4 Pharmaceuticals?
  • Does X4 Pharmaceuticals pay dividends?
  • What sector is X4 Pharmaceuticals in?
  • What industry is X4 Pharmaceuticals in?
  • What country is X4 Pharmaceuticals based in?
  • When did X4 Pharmaceuticals go public?
  • Is X4 Pharmaceuticals in the S&P 500?
  • Is X4 Pharmaceuticals in the NASDAQ 100?
  • Is X4 Pharmaceuticals in the Dow Jones?
  • When was X4 Pharmaceuticals's last earnings report?
  • When does X4 Pharmaceuticals report earnings?
  • Should I buy X4 Pharmaceuticals stock now?

What is the ticker symbol for X4 Pharmaceuticals?

The ticker symbol for X4 Pharmaceuticals is NASDAQ:XFOR

Does X4 Pharmaceuticals pay dividends?

No, X4 Pharmaceuticals does not pay dividends

What sector is X4 Pharmaceuticals in?

X4 Pharmaceuticals is in the Healthcare sector

What industry is X4 Pharmaceuticals in?

X4 Pharmaceuticals is in the Biotechnology industry

What country is X4 Pharmaceuticals based in?

X4 Pharmaceuticals is headquartered in United States

When did X4 Pharmaceuticals go public?

X4 Pharmaceuticals's initial public offering (IPO) was on November 16, 2017

Is X4 Pharmaceuticals in the S&P 500?

No, X4 Pharmaceuticals is not included in the S&P 500 index

Is X4 Pharmaceuticals in the NASDAQ 100?

No, X4 Pharmaceuticals is not included in the NASDAQ 100 index

Is X4 Pharmaceuticals in the Dow Jones?

No, X4 Pharmaceuticals is not included in the Dow Jones index

When was X4 Pharmaceuticals's last earnings report?

X4 Pharmaceuticals's most recent earnings report was on Nov 13, 2024

When does X4 Pharmaceuticals report earnings?

The next expected earnings date for X4 Pharmaceuticals is Mar 21, 2025

Should I buy X4 Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions